Job Opportunities API

The Public Ledger of Openings

← Back to the ledger

Senior Manager, SEC Reporting

Remix Therapeutics
CompanyRemix Therapeutics
CategoryFinance
LocationWatertown
RemoteOn-site (inferred)
EmploymentNot stated
LevelSenior
SalaryNot stated by the employer
Posted8 Jun 2026
Last verified2 Aug 2026
SourceEmployer career page (greenhouse)
Applications are handled by the employer, not by us.Apply on the employer's site →
Description
Remix launched with a vision to transform patients’ lives through modulation of RNA processing.  Our breakthrough science enables the identification of small molecules that influence the expression of  disease ‑ driving  mRNAs and proteins. We focus on diseases of high unmet medical need and are committed to  operating  with scientific rigor and urgency. With a proprietary  in ‑ house  technology platform, we have rapidly generated multiple discovery programs advancing toward the clinic. Remix Therapeutics was recognized as one of  BioSpace’s  Best Places to Work in Boston 2025 and is backed by leading life sciences investors.   Position Summary: The Senior Manager, SEC Reporting will play a critical role in supporting public company readiness initiatives and leading external financial reporting activities. Reporting to the Head of Finance, this individual will be responsible for preparing SEC filings, supporting technical accounting matters, and helping establish scalable reporting and compliance processes appropriate for a public company environment. The ideal candidate will bring strong technical accounting expertise, excellent project management capabilities, and the ability to work independently in a fast-paced clinical-stage biotech environment.   This is an exciting opportunity to join a growing clinical-stage biotechnology company at a transformational stage and help build the infrastructure of a future public company. The role offers meaningful exposure to executive leadership, opportunities for professional growth, and the ability to make a significant impact on the organization’s future success.    Key Responsibilities: Prepare and coordinate SEC filings, including Forms S-1, 10-Q, 10-K, 8-K, and related disclosures and supporting schedules   Draft and review footnote disclosures and MD&A  in accordance with  U.S. GAAP and SEC reporting requirements   Support IPO readiness activities, including implementation of disclosure controls and SOX compliance processes   Partner cross-functionally with FP&A, Legal, HR, Clinical Operations, and external auditors/advisors to gather and  validate  information for filings   Research technical accounting matters and prepare accounting memoranda   Coordinate reporting timelines and ensure  timely  and  accurate  filings   Support quarterly and annual close activities related to external reporting   Assist  with equity accounting and stock compensation reporting   Monitor new accounting pronouncements and SEC regulations and assess their impact on the company   Drive process improvements and help build scalable reporting infrastructure as the organization grows   Personal Attributes: Highly detail-oriented with strong analytical and problem-solving skills   Hands-on, proactive, and solutions-oriented mindset   Comfortable operating in a dynamic, fast-paced environment   Collaborative team player with strong interpersonal skills   Ability to  maintain  confidentiality and exercise sound judgment   Qualifications: Required   Bachelor's degree in accounting or finance     Active CPA license  required   Minimum  5+ years of progressive accounting and financial reporting experience   Big 4 public accounting experience   Clinical-stage biotechnology or life sciences industry experience   Strong understanding of U.S. GAAP and SEC reporting requirements   Strong written
HOUSE ADYou found the opening. Now track it.Tracker, radar and AI drafts in one place.erioun.com →